Vascular Perfusion Solutions, Inc.

SAN ANTONIO, TX · Founded 2016 · Medtech · Private

Perfusion systems and devices for organ preservation and transplantation

Claim this profile

Follows are private to you and power your alerts

Updated · vascularperfusionsolutions.com

Sector
Medtech
Headquarters
SAN ANTONIO, TX
Founded
2016
Latest Form D
$147M, May 2025
Total capital
$155M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$155M
8 Form D · last May 2025
17 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2019202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $155M1st Form D$2M3rd Form D$2.4M8th Form D$147M
2019202120232025FEDERAL ↑EQUITY ↓Cumulative $155M8th Form D$147M

Latest events

  • Private capital raisedForm D · SEC · 8th filing$147M
  • Private capital raisedForm D · SEC · 7th filing$500K
  • Private capital raisedForm D · SEC · 6th filing$500K
  • Private capital raisedForm D · SEC · 5th filing$850K
  • Private capital raisedForm D · SEC · 4th filing$1.1M
  • Private capital raisedForm D · SEC · 3rd filing$2.4M
  • Private capital raisedForm D · SEC · 2nd filing$602K
  • Private capital raisedForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Celia JairalaDirectorNamed in SEC Form D filings
  • C. Thomas MayesExecutive Officer, DirectorNamed in SEC Form D filings
  • Klaus WeiswurmDirectorNamed in SEC Form D filings
  • Kristina Thomas AndrijauskaiteExecutive OfficerNamed in SEC Form D filings
  • Leon BuneginDirectorNamed in SEC Form D filings
  • Mark MullerExecutive Officer, DirectorNamed in SEC Form D filings
Show all 10 people
  • Paul PerryExecutive OfficerNamed in SEC Form D filings
  • Rafael VerazaExecutive Officer, DirectorNamed in SEC Form D filings
  • Tom DeBrookeExecutive Officer, DirectorNamed in SEC Form D filings
  • Toni Thomas HaenninenExecutive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .